The most important financial indicators for the company Gastro Oncology Research S.r.l. - Unique Identification Number 16611590:
sales in 2023 was
50.555
euro, registering a net profit of
37.242
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 116.4%, from 23.435 euro in the year 2022, to 50.555 euro in 2023.
The Net Profit increased by 21.709 euro, from 15.580 euro in 2022, to 37.242 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Gastro Oncology Research S.r.l. - CUI 16611590
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
30.697
21.360
13.890
4.120
1.485
2.503
1.492
3.079
1.948
1.080
Current Assets
33.801
24.550
3.535
17.395
37.624
53.042
44.771
12.414
13.858
38.364
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
0
0
0
10.662
1.199
0
1.590
1.160
254
2.365
Cash
33.801
24.550
3.535
6.733
36.425
53.042
43.181
11.255
13.604
35.999
Shareholders Funds
40.417
10.521
7.565
17.045
38.237
55.434
44.038
12.777
15.628
37.290
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
24.082
35.389
9.860
4.470
872
111
2.224
2.716
178
2.153
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
38.364 euro in 2023 which includes Inventories of
0 euro, Receivables of
2.365 euro and cash availability of
35.999 euro.
The company's Equity was valued at
37.290 euro, while total Liabilities amounted to
2.153 euro.
Equity increased by 21.709 euro, from 15.628 euro in 2022, to 37.290 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Gastro Oncology Research S.r.l.